Elevance Health’s 33.1% return over the past six months has outpaced the S&P 500 by 23.1%, and its stock price has climbed to ...

Elevance Health Inc. (NYSE:ELV) is one of the cheap S&P 500 stocks to invest in now. On January 9, Mizuho analyst Ann Hynes ...

Elevance Health (ELV) came out with quarterly earnings of $11.97 per share, beating the Zacks Consensus Estimate of $11.21 per share. This compares to earnings of $10.64 per share a year ago. These ...

Elevance Health (ELV) shares rallied 5.4% in the last trading session to close at $452.69. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

Trained providers to screen, enroll eligible members to receive evidence-based nutrition and dietary services. INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health (ELV) and the National Association of ...

INDIANAPOLIS--(BUSINESS WIRE)--The Whole Health Index (WHI), created by Elevance Health, Inc. (NYSE: ELV) physicians, data scientists, and researchers, is a first-of-its-kind assessment of health.

Anthem, now Elevance Health, has agreed to a $12.8 million settlement in a class action lawsuit over denied coverage for ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. Markets had a difficult start to 2025; ...

This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events ...

INDIANAPOLIS--(BUSINESS WIRE)-- As 2025 draws to a close, Elevance Health highlights how today’s health plans are evolving to better support their members in a broader range of situations that affect ...

Elevance Health, Inc. (NYSE:ELV) is one of the best affordable healthcare stocks to buy now. Elevance Health, Inc. (NYSE:ELV) was downgraded to Hold from Buy by Deutsche Bank analyst George Hill on ...